Proteomic analysis of Terminalia chebula extract-dependent changes in human lymphoblastic T cell protein expression
- PMID: 22471968
- PMCID: PMC3382265
- DOI: 10.1089/jmf.2011.1998
Proteomic analysis of Terminalia chebula extract-dependent changes in human lymphoblastic T cell protein expression
Abstract
Terminalia chebula is a native plant from southern Asia to southwestern China that is used in traditional medicine for the treatment of malignant tumors and diabetes. This plant also has antibacterial and immunomodulatory properties. The present study assessed T. chebula extract-dependent protein expression changes in Jurkat cells. Matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry and Ingenuity Pathways Analysis (IPA) were performed to assess protein expression and networks, respectively. A comparative proteomic profile was determined in T. chebula extract (50 μg/mL)-treated and control cells; the expressions of β-tubulin, ring finger and CHY zinc finger domain containing 1, and insulin-like growth factor 1 receptor kinase were significantly down-regulated in T. chebula extract-treated Jurkat cells. Moreover, the molecular basis for the T. chebula extract-dependent protein expression changes in Jurkat cells was determined by IPA. Treatment with the T. chebula extract significantly inhibited nuclear factor-κB activity and affected the proteomic profile of Jurkat cells. The molecular network signatures and functional proteomics obtained in this study may facilitate the evaluation of potential antitumor therapeutic targets and elucidate the molecular mechanism of T. chebula extract-dependent effects in Jurkat cells.
Figures


Similar articles
-
Terminalia chebula extract acts as a potential NF-κB inhibitor in human lymphoblastic T cells.Phytother Res. 2011 Jun;25(6):927-34. doi: 10.1002/ptr.3398. Phytother Res. 2011. PMID: 21509843
-
Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.BMC Complement Altern Med. 2017 Feb 14;17(1):110. doi: 10.1186/s12906-017-1620-8. BMC Complement Altern Med. 2017. PMID: 28196487 Free PMC article.
-
Fenugreek extract as an inducer of cellular death via autophagy in human T lymphoma Jurkat cells.BMC Complement Altern Med. 2012 Oct 30;12:202. doi: 10.1186/1472-6882-12-202. BMC Complement Altern Med. 2012. PMID: 23110539 Free PMC article.
-
Potential therapeutic applications for Terminalia chebula in Iranian traditional medicine.J Tradit Chin Med. 2016 Apr;36(2):250-4. doi: 10.1016/s0254-6272(16)30035-8. J Tradit Chin Med. 2016. PMID: 27400482 Review.
-
Fruits of Terminalia chebula Retz.: A review on traditional uses, bioactive chemical constituents and pharmacological activities.Phytother Res. 2020 Oct;34(10):2518-2533. doi: 10.1002/ptr.6702. Epub 2020 Apr 20. Phytother Res. 2020. PMID: 32307775 Review.
Cited by
-
The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae).Inflammopharmacology. 2015 Oct;23(5):203-29. doi: 10.1007/s10787-015-0246-z. Epub 2015 Jul 31. Inflammopharmacology. 2015. PMID: 26226895 Review.
-
Endophytic Fungi from Terminalia Species: A Comprehensive Review.J Fungi (Basel). 2019 May 24;5(2):43. doi: 10.3390/jof5020043. J Fungi (Basel). 2019. PMID: 31137730 Free PMC article. Review.
-
Potential Distribution Prediction of Terminalia chebula Retz. in China Under Current and Future Climate Scenarios.Ecol Evol. 2025 Jan 28;15(2):e70908. doi: 10.1002/ece3.70908. eCollection 2025 Feb. Ecol Evol. 2025. PMID: 39896773 Free PMC article.
References
-
- Fabry W. Okemo PO. Ansorg R. Antibacterial activity of East African medicinal plants. J Ethnopharmacol. 1998;60:79–84. - PubMed
-
- Sabu MC. Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81:155–160. - PubMed
-
- Saleem A. Husheem M. Harkonen P. Pihlaja K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J Ethnopharmacol. 2002;81:327–336. - PubMed
-
- Reddy DB. Reddy TC. Jyotsna G, et al. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line. J Ethnopharmacol. 2009;124:506–512. - PubMed
-
- Abraham RT. Weiss A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat Rev Immunol. 2004;4:301–308. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical